These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 8622643

  • 1. Comparison of duration of agonist action at beta 1- and beta 2- adrenoceptors in C6 glioma cells: evidence that the long duration of action of salmeterol is specific to the beta 2-adrenoceptor.
    McCrea KE, Hill SJ.
    Mol Pharmacol; 1996 May; 49(5):927-37. PubMed ID: 8622643
    [Abstract] [Full Text] [Related]

  • 2. Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.
    Scola AM, Chong LK, Suvarna SK, Chess-Williams R, Peachell PT.
    Br J Pharmacol; 2004 Jan; 141(1):163-71. PubMed ID: 14662724
    [Abstract] [Full Text] [Related]

  • 3. Kinetic analysis of drug-receptor interactions of long-acting beta2 sympathomimetics in isolated receptor membranes: evidence against prolonged effects of salmeterol and formoterol on receptor-coupled adenylyl cyclase.
    Teschemacher A, Lemoine H.
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1084-92. PubMed ID: 10027845
    [Abstract] [Full Text] [Related]

  • 4. Salmeterol, a long-acting beta 2-adrenoceptor agonist mediating cyclic AMP accumulation in a neuronal cell line.
    McCrea KE, Hill SJ.
    Br J Pharmacol; 1993 Oct; 110(2):619-26. PubMed ID: 7902176
    [Abstract] [Full Text] [Related]

  • 5. Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.
    Ryall JG, Sillence MN, Lynch GS.
    Br J Pharmacol; 2006 Mar; 147(6):587-95. PubMed ID: 16432501
    [Abstract] [Full Text] [Related]

  • 6. A cell-based assay to assess the persistence of action of agonists acting at recombinant human beta(2) adrenoceptors.
    Summerhill S, Stroud T, Nagendra R, Perros-Huguet C, Trevethick M.
    J Pharmacol Toxicol Methods; 2008 Mar; 58(3):189-97. PubMed ID: 18652905
    [Abstract] [Full Text] [Related]

  • 7. The duration of action of non-beta 2-adrenoceptor mediated responses to salmeterol.
    Nials AT, Coleman RA, Johnson M, Vardey CJ.
    Br J Pharmacol; 1997 Mar; 120(5):961-7. PubMed ID: 9138705
    [Abstract] [Full Text] [Related]

  • 8. Duration of action of inhaled vs. Intravenous beta(2)-adrenoceptor agonists in an anaesthetized guinea-pig model.
    Mohammed SP, Taylor CV, Weyman-Jones CB, Mather ME, Vendy K, Dougall IG, Young A.
    Pulm Pharmacol Ther; 2000 Mar; 13(6):287-92. PubMed ID: 11061983
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological characterization of abediterol, a novel inhaled β(2)-adrenoceptor agonist with long duration of action and a favorable safety profile in preclinical models.
    Aparici M, Gómez-Angelats M, Vilella D, Otal R, Carcasona C, Viñals M, Ramos I, Gavaldà A, De Alba J, Gras J, Cortijo J, Morcillo E, Puig C, Ryder H, Beleta J, Miralpeix M.
    J Pharmacol Exp Ther; 2012 Aug; 342(2):497-509. PubMed ID: 22588259
    [Abstract] [Full Text] [Related]

  • 10. Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus.
    Naline E, Zhang Y, Qian Y, Mairon N, Anderson GP, Grandordy B, Advenier C.
    Eur Respir J; 1994 May; 7(5):914-20. PubMed ID: 7914176
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the profiles of agonists as stimulants of the beta 3-adrenoceptor in vitro with their gastroprotective effects in the conscious rat.
    Bahl AK, Clayton NM, Coates J, Martin DP, Oakley IG, Strong P, Trevethick MA.
    Br J Pharmacol; 1996 Feb; 117(3):580-586. PubMed ID: 8821552
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological characterization of indacaterol, a novel once daily inhaled 2 adrenoceptor agonist, on small airways in human and rat precision-cut lung slices.
    Sturton RG, Trifilieff A, Nicholson AG, Barnes PJ.
    J Pharmacol Exp Ther; 2008 Jan; 324(1):270-5. PubMed ID: 17916760
    [Abstract] [Full Text] [Related]

  • 13. Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells.
    Carter AA, Hill SJ.
    J Pharmacol Exp Ther; 2005 Nov; 315(2):839-48. PubMed ID: 16051698
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacological properties of salmeterol].
    Bousquet J, Michel FB.
    Rev Mal Respir; 1992 Nov; 9 Suppl 1():R7-10. PubMed ID: 1350370
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
    Grove A, Lipworth BJ.
    Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
    [Abstract] [Full Text] [Related]

  • 16. Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists.
    Kikkawa H, Kurose H, Isogaya M, Sato Y, Nagao T.
    Br J Pharmacol; 1997 Jul; 121(6):1059-64. PubMed ID: 9249239
    [Abstract] [Full Text] [Related]

  • 17. Influence of receptor number on the stimulation by salmeterol of gene transcription in CHO-K1 cells transfected with the human beta2-adrenoceptor.
    McDonnell J, Latif ML, Rees ES, Bevan NJ, Hill SJ.
    Br J Pharmacol; 1998 Oct; 125(4):717-26. PubMed ID: 9831907
    [Abstract] [Full Text] [Related]

  • 18. [Inquiry into the mechanism of long-acting bronchodilators].
    Bao Y, Lemoine H.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):191-6. PubMed ID: 11367704
    [Abstract] [Full Text] [Related]

  • 19. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms.
    Chong LK, Cooper E, Vardey CJ, Peachell PT.
    Br J Pharmacol; 1998 Mar; 123(5):1009-15. PubMed ID: 9535032
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.
    Lindén A, Rabe KF, Löfdahl CG.
    Lung; 1996 Mar; 174(1):1-22. PubMed ID: 8746998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.